ATE441423T1 - Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen - Google Patents

Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen

Info

Publication number
ATE441423T1
ATE441423T1 AT03731077T AT03731077T ATE441423T1 AT E441423 T1 ATE441423 T1 AT E441423T1 AT 03731077 T AT03731077 T AT 03731077T AT 03731077 T AT03731077 T AT 03731077T AT E441423 T1 ATE441423 T1 AT E441423T1
Authority
AT
Austria
Prior art keywords
cell proliferation
microbial infections
mastix
prevent
microbial
Prior art date
Application number
AT03731077T
Other languages
English (en)
Inventor
Spiros Fotinos
Ligia Panaitescu
Dimitris Kletsas
Harris Platsinis
Irene Zervolea
Alexios-Leandros Skaltsounis
Sofia Mitakou
Prokopios Magiatis
Original Assignee
Lavipharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lavipharm Sa filed Critical Lavipharm Sa
Application granted granted Critical
Publication of ATE441423T1 publication Critical patent/ATE441423T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
AT03731077T 2002-05-01 2003-05-01 Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen ATE441423T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37679002P 2002-05-01 2002-05-01
US41166502P 2002-09-18 2002-09-18
PCT/US2003/013728 WO2003092712A1 (en) 2002-05-01 2003-05-01 Use of mastic and its components for the control of microbial infections

Publications (1)

Publication Number Publication Date
ATE441423T1 true ATE441423T1 (de) 2009-09-15

Family

ID=29406768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03731077T ATE441423T1 (de) 2002-05-01 2003-05-01 Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen

Country Status (6)

Country Link
US (1) US20050238740A1 (de)
EP (1) EP1501527B1 (de)
AT (1) ATE441423T1 (de)
AU (1) AU2003241345A1 (de)
DE (1) DE60329098D1 (de)
WO (1) WO2003092712A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014730A1 (en) * 2003-04-02 2005-01-20 Carlson Robert M. Anti-fungal formulation of triterpene and essential oil
US20050074509A1 (en) 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
FR2867980B1 (fr) * 2004-03-23 2006-07-14 Pierre Fabre Medicament Sa Utilisation de l'acide masticadienonique en tant qu'inhibiteur de l'adn polymerase beta
US20080199549A1 (en) * 2007-02-16 2008-08-21 Bionature E. A. Limited Treatment and prevention of inflammation
EP1958641A1 (de) * 2007-02-16 2008-08-20 Bionature E.A. Limited Behandlung und Prävention von Entzündungen
KR101071502B1 (ko) * 2008-06-18 2011-10-10 한국콜마 주식회사 매스틱을 포함하는 발포성 속붕해정
KR101016832B1 (ko) 2008-06-19 2011-02-22 한국콜마 주식회사 위장관 궤양의 치료를 위한 매스틱 함유 복합제제
WO2010030082A2 (ko) * 2008-09-11 2010-03-18 주식회사 엠디코드 매스틱 추출물 및 그 추출방법
WO2010100651A2 (en) * 2009-03-04 2010-09-10 Regenera Pharma Ltd. Compositions of polymeric myrcene
PL2403505T3 (pl) * 2009-03-04 2017-06-30 Regenera Pharma Ltd. Terapeutyczne zastosowania frakcji gumy mastyksowej
JP5578880B2 (ja) * 2010-02-25 2014-08-27 株式会社アライアンス 抗マラセチア菌剤
BR112013005300B1 (pt) * 2010-09-07 2021-11-09 Regenera Pharma Ltd Composição que compreende extratos ácidos de goma mástique
IL237621A0 (en) 2015-03-08 2015-06-30 Regenera Pharma Ltd Use of isolated fractions of the gum goddess to treat optic neuropathy
KR20180054821A (ko) * 2015-09-24 2018-05-24 레제네라 파마 리미티드 트리테르페노이드 포함 조성물
EP3352742B1 (de) 2015-09-24 2021-11-03 Regenera Pharma Ltd. Zusammensetzungen mit triterpenoiden zur behandlung der alzheimer- und parkinson-krankheit
CN109906104A (zh) * 2016-09-08 2019-06-18 瑞吉纳拉制药公司 包括三萜类的组合物及其用于治疗视神经病变的用途
JP7074352B2 (ja) * 2016-09-08 2022-05-24 レジネラ ファーマ リミテッド 視神経症を処置するためのマスチックガムの酸性抽出物を含む組成物およびその使用
IT201700016726A1 (it) 2017-02-15 2018-08-15 Phytoitalia Srl Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
EP3363440A1 (de) * 2017-02-21 2018-08-22 University Of Athens Hemmung des wachstums oraler mikroben durch eine verbindung aus pistacia lentiscus
EP3459368B1 (de) * 2017-09-20 2025-08-20 Geophyt S.r.L. Lebensmittelintegrator für antineoplastische therapien
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
US12029773B2 (en) 2018-05-14 2024-07-09 Barentz North America, Llc Mastic-derived natural protectants
JP7723397B2 (ja) * 2018-08-09 2025-08-14 株式会社 ソーシン 口腔内抗菌用機能性食品組成物
CN109248103A (zh) * 2018-10-30 2019-01-22 武汉卫无忧生物科技有限公司 一种抗幽门螺杆菌的口腔清洁用品
CN110742833B (zh) * 2019-11-28 2022-08-09 广州环亚化妆品科技股份有限公司 一种祛痘美白抗衰老的精油组合物及其制备方法和应用
GR20220100088A (el) * 2022-01-28 2023-08-08 Thracell Προηγμενες Βιοτεχνολογικες Εφαρμογες Μονοπροσωπη Ανωνυμη Εταιρεια, Συνθεση με αντιγηραντικες, αντιοξειδωτικες ικανοτητες και ευεργετικες ιδιοτητες που συντελουν στην ευζωια

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483289A (en) * 1963-07-12 1969-12-09 Angie F Criswell Human nail coating compositions
GR950100243A (el) * 1995-06-28 1997-02-28 �. �����- �. ����� �.�.�. Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
GR1003541B (el) * 1999-05-11 2001-03-07 Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el) * 1999-09-22 2001-03-13 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
JP4601100B2 (ja) * 1999-11-08 2010-12-22 三生医薬株式会社 マスティックの油液を内包した軟カプセル
US6623728B2 (en) * 2000-06-30 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic skin care compositions and containing gum mastic
EP1178104A1 (de) * 2000-08-03 2002-02-06 Société des Produits Nestlé S.A. Verwendung ätherische Öle zur Bekämpfung von GI- Trakt- Infektion durch Helicobacterartige Organismen
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
GR1003832B (el) * 2001-04-30 2002-03-04 Γεωργιος Σοδης Χρηση του μαστιχελαιου και της φυσικης μαστιχας για την παραγωγη φαρμακευτικων, παραφαρμακευτικων και καλλυντικων προιοντων

Also Published As

Publication number Publication date
DE60329098D1 (de) 2009-10-15
US20050238740A1 (en) 2005-10-27
EP1501527B1 (de) 2009-09-02
WO2003092712A1 (en) 2003-11-13
EP1501527A1 (de) 2005-02-02
AU2003241345A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
GEAP202416515A (en) Quinoline compounds as inhibitors of kras
MEP25008A (en) Topical methadone compositions and methods for using the same
EP4566675A3 (de) Heterocyclische verbindungen als immunmodulatoren
NO20055722D0 (no) Antiseptiske preparater, fremgangsmater og systemer
NO20074980L (no) Sammensetninger og fremgangsmater for topisk paforing og transdermal avlevering av botulinumtoksiker.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
MEP36908A (en) omega-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
GB0022438D0 (en) Organic Compounds
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
BR0312000A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
WO2009043987A9 (fr) Compositions antibiotiques a base d'huiles essentielles - prophylaxie et traitement d'infections nosocomiales
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
MX2025002705A (es) Isoquinolonas como inhibidores de pi3k
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
BRPI0409884A (pt) compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties